Skip to main content

Oncology Central is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • News
  • Events coverage
  • Features
    • Opinion
    • Journal articles
    • Events calendar
    • Spotlights
    • In Focus

    Follow us on social media

  • Our Journals
  • Topic
    • Prevention, detection and screening
      • Biomarkers
      • Diagnostics
      • Epidemiology
      • Genetics & genomics
      • Prevention & screening
    • Bench to bedside
      • Cancer biology
      • Clinical trials
      • Drug approvals
      • Drug development
      • Emerging technologies
      • Industry & business
      • Preclinical research
    • Treatments
      • Chemotherapy
      • Immuno-oncology
      • Personalized & precision medicine
      • Radiology
      • Surgery
      • Targeted therapies
    • Supportive oncology
      • Palliative care
      • Patient perspectives
      • Quality of life
      • Survivorship
      • Virtual healthcare

    Follow us on social media

  • Disease specialty
    • Breast
    • Colorectal
    • Endocrine
    • Gastrointestinal
    • Genitourinary
    • Gynecologic
    • Head & neck
    • Hematologic
    • Hepatic
    • Lung
    • Neurologic
    • Pancreatic
    • Prostate
    • Rare tumors
    • Renal
    • Skin

    Follow us on social media

  • Multimedia
    • Videos
    • Podcasts
    • Infographics
    • Webinars
    • Downloadable eBooks

    Follow us on social media

  • Register
[COFFEE CHAT] The emotional and psychological impact of hepatocellular carcinoma on patients, families and caregivers WATCH NOW

Patient perspective

Cancer is a unique disease in both biology and how it affects patients who are diagnosed, which leads to unique patient perspectives that are invaluable to the research and development of new treatments.

View more

The symptomatic, psychosocial and spiritual perspectives that patients gain once diagnosed have been both well documented by patients and often misunderstood by researchers. It is therefore implicit that the concept of a patient perspective includes how it can be effectively communicated, interpreted and acted upon by researchers and physicians.

Patient advocacy and patient engagement are two relatively recent concepts that have improved our understanding of the benefits of the patient perspective. Patient advocacy is focused on conveying the perspectives and ensuring they are acted upon appropriately, whilst patient engagement refers to the role of researchers in gaining the patient perspective for their work. Patient perspectives have helped to improve many aspects of healthcare, including clinical trials, screening and early diagnosis, health economics and outcomes research, use of electronic health records and addressing healthcare disparities, although this is far from an exhaustive list.

Although most would associate patient perspectives with the patient themselves, anyone affected by the disease could give valuable insight to researchers and clinicians. It can include friends, carers and families, but it should be noted that each will have their own interpretation of cancer and true patient engagement should seek to include perspectives from everyone.

  • About
  • Accessibility
  • Advertising & Sponsorship
  • Contact Us
  • Editorial Policies
  • Expert Panel
  • Journals
  • Permissions and content ownership policy
  • Press release policy
  • Whitelist emails

Contact

Contact Us

Office info

Oncology Central is powered by Taylor & Francis Group

Oncology Central, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Oncology Central